New Times,
New Thinking.

  1. Politics
22 November 2017

New Statesman wins Current Affairs Magazine and Launch of the Year at BSME Awards

Judges described the New Statesman as "consistently fresh and thought provoking". 

By New Statesman

The New Statesman won two prestigious British Society of Magazine Editors (BSME) awards last night, including the Current Affairs and Politics editor of the year award for Jason Cowley.

The shortlisted titles included the Spectator, the Economist and Prospect.

“The winning title is consistently fresh and thought provoking. In a very strong category it stood out for its eloquence and independent views,” the BSME judges said, on presenting the award.

The New Statesman’s Spotlight series (which publishes specialist business content) also won the Launch of the Year award, with judges describing the supplements as a “great example of monetising a brand without losing its integrity”.

Jason Cowley said: “I’m delighted for my team, the best I’ve ever worked with. The New Statesman has evolved into being a print-digital hybrid but as well as expanding our website we remain committed to publishing a high quality magazine, which is politically independent and determined to explain and analyse the forces shaping our world today and creating the history of our era.”

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Nutrition must be central to Labour's health mission
How we can continue to innovate in the care of rare diseases
The right deal for all